- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Paul B. Manning
- Signature - Title
- /s/ Paul B. Manning - Paul B. Manning
- Location
- Charlottesville, VA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Paul B. Manning.
Follow Filing Activity
Follow Paul B. Manning and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Paul B. Manning
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | ||
| TSHA | TAYSHA GENE THERAPIES, INC. | Common Stock, $0.00001 par value per share | 9.8% | $59,394,578 | 25,601,111 | Paul B Manning | 30 May 2025 | ||
| CADL | CANDEL THERAPEUTICS, INC. | Common Stock, $0.01 par value per share | 7.9% | $29,997,375 | 5,790,999 | Paul B Manning | 16 Dec 2024 |
Schedules 13D/G Reported by Paul B. Manning:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.